Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response.

BACKGROUND: Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments. AIM: To assess the effectiveness and the safety of RFA in patients with early HCC and compensated cirrhosis. METHOD...

Full description

Bibliographic Details
Main Authors: Giuseppe Cabibbo, Marcello Maida, Chiara Genco, Nicola Alessi, Marco Peralta, Giuseppe Butera, Massimo Galia, Giuseppe Brancatelli, Claudio Genova, Maurizio Raineri, Emanuele Orlando, Simona Attardo, Antonino Giarratano, Massimo Midiri, Vito Di Marco, Antonio Craxì, Calogero Cammà
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3726477?pdf=render